T1	Participants 126 186	Ninety-seven women with moderate to severe preeclampsia (PE)
T2	Participants 261 284	22 women with severe PE
T3	Participants 357 362	Seven
T4	Participants 457 488	seven women received both drugs
T5	Participants 1060 1104	Five of the 11 neonates with gestational age
